Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma

被引:15
|
作者
Wu, F. [1 ]
Wu, S. [2 ]
Gou, X. [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, Chongqing 400016, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Chongqing 400016, Peoples R China
关键词
clear cell renal cell carcinoma; differentially expressed gene; protein-protein interaction network; miRNA; survival analysis; TUMOR-STROMA COEVOLUTION; OXIDATIVE STRESS; WEB SERVER; CANCER; EXPRESSION; HYPOXIA; PATHWAYS; INVASION; PROLIFERATION; APOPTOSIS;
D O I
10.4149/neo_2018_170511N342
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cancer in adults. The aim of this study is to identify the biomarkers and potential molecular mechanisms of ccRCC. Three gene expression profiles and two miRNA expression profiles were downloaded from GEO database. A total of 330 up-regulated differentially expressed genes (DEGs), 545 down-regulated DEGs, 26 up-regulated differentially expressed miRNAs (DEMs) and 11 down-regulated DEMs were identified by GEO2R. The gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed by KOBAS soft ware. The results showed that GO terms of the up-regulated DEGs were mostly enriched in response to stimulus at BP level, cell periphery at CC level and binding at MF level, while the GO terms of down-regulated DEGs were enriched in single-organism process at BP level, extracellular exosome at CC level and catalytic activity at MF level. As for KEGG pathways, HIF-1 signaling pathway, focal adhesion, PI3K-Akt signaling pathway and metabolic pathways were significantly enriched. Then, protein-protein interaction (PPI) network and miRNA-gene network were constructed and analyzed by Cytoscape. A total of eight DEGs were identified as biomarkers, including VEGFA, PPARA, CCND1, FLT1, CXCL12, FN1, DCN and ERBB4. Expression validation and survival analysis were performed by GEPIA and OncoLnc, respectively. Four biomarkers were verified by quantitative real-time PCR (qPCR) in 786-O cell line and HK-2 cell line. All four genes had the same expression trend as predicted. Our study provides a series of biomarkers and molecular mechanisms for the deeper research of ccRCC.
引用
收藏
页码:242 / 252
页数:11
相关论文
共 50 条
  • [31] Identification of novel biomarkers to distinguish clear cell and non-clear cell renal cell carcinoma using bioinformatics and machine learning
    Panwoon, Chanita
    Seubwai, Wunchana
    Thanee, Malinee
    Sangkhamanon, Sakkarn
    PLOS ONE, 2024, 19 (06):
  • [32] DNA methylation biomarkers of clear cell renal carcinoma
    Kubiliute, R.
    Zukauskaite, K.
    Zalimas, A.
    Ulys, A.
    Jankevicius, F.
    Jarmalaite, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1224 - S1225
  • [33] Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma
    Cotta, Brittney H.
    Choueiri, Toni K.
    Cieslik, Marcin
    Ghatalia, Pooja
    Mehra, Rohit
    Morgan, Todd M.
    Palapattu, Ganesh S.
    Shuch, Brian
    Vaishampayan, Ulka
    Van Allen, Eliezer
    Hakimi, Ari
    Salami, Simpa S.
    EUROPEAN UROLOGY, 2023, 84 (02) : 166 - 175
  • [34] Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma
    Ackroyd, Sarah A.
    Arguello, David
    Ramos, Pilar
    Mahdi, Haider
    ElNaggar, Adam
    Winer, Ira
    Holloway, Rob
    Krivak, Thomas
    Jones, Nathaniel
    Turner, Valerie Galvan
    Herzog, Thomas
    Chu, Christina
    Brown, Jubilee
    Mantia-Smaldone, Gina
    GYNECOLOGIC ONCOLOGY, 2023, 169 : 164 - 171
  • [35] Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma
    Mantia-Smaldone, G. M.
    Arguello, D.
    Mahdi, H.
    ElNaggar, A. C.
    Winer, I.
    Holloway, R. W.
    Krivak, T. C.
    Jones, N. L.
    Galvan-Turner, V.
    Herzog, T. J.
    Chu, C.
    Brown, J.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 175 - 175
  • [36] Prognostic biomarkers in patients with clear cell renal cell carcinoma (ccRCC)
    Gandur Quiroga, Maria N.
    Knott, Maria E.
    Pulero, Carla
    Pasik, Leonardo
    Alvarez, Ana M.
    Brzezinski, Mariano
    Malagrino, Hector
    Bal de Kier Joffe, Elisa D.
    Puricelli, Lydia I.
    CANCER RESEARCH, 2012, 72
  • [37] Surgical ischemia and detection of clear cell renal cell carcinoma biomarkers
    Gedye, Craig
    Kurban, Ghada
    Gallie, Brenda L.
    Leveridge, Michael John
    Musquera, Mireia
    Morales, Carlos
    Brooks, Samira A.
    Tsavachldou, Dimitra
    Finelli, Antonio
    Evans, Andrew
    Jonasch, Eric
    Rathmell, Kimryn
    Jewett, Michael A. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [38] Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics
    Li, Wen
    Wang, Xiaobin
    Zhang, Xianbin
    Gong, Peng
    Ding, Degang
    Wang, Ning
    Wang, Zhifeng
    LIPIDS IN HEALTH AND DISEASE, 2021, 20 (01)
  • [39] MicroRNAs and altered metabolism of clear cell renal cell carcinoma: Potential role as aerobic glycolysis biomarkers
    Morais, Mariana
    Dias, Francisca
    Teixeira, Ana L.
    Medeiros, Rui
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2017, 1861 (09): : 2175 - 2185
  • [40] Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
    Zhang, Yan
    Chen, Mingying
    Liu, Meihong
    Xu, Yingkun
    Wu, Guangzhen
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021